Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial
Waijer SW, Vart P, Cherney DZI, et al.
Diabetologia. Pub. online 21 Apr 2022.
Leggi
Waijer SW, Vart P, Cherney DZI, et al.
Diabetologia. Pub. online 21 Apr 2022.
Leggi
Torbey MT, Pauls Q, Gentile N, et al.
Stroke. 2022;53(5):1510-5.
Leggi
Li S, Levy WC
J Am Coll Cardiol HF. Pub. online 06 Apr 2022
Leggi
Soulimane S, Balkau B, Vogtschmidt YD, et al.
Diabetologia. Pub. online 12 Apr 2022
Leggi
Li N, Tan H, Xie A, et al.
BMC Endocrine Disorders. 2022;22(1):101
Leggi
Russo GT, Corigliano G, Arturi F, et al.
Nutr Metab Cardiovasc Dis. 2022;32(5):1195-1201
Leggi
Tamborlane WV, Laffel LM, Shehadeh N, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00052-3
Leggi
Neuen BL, Oshima M, Agarwal R, et al.
Circulation. Pub. online 8 Apr 2022
Leggi
Renard E, Riveline JP, Hanaire H, et al.
Diabetes Obes Metab. 2022;24(5):859-867
Leggi
Song Z, Cheng Y, Li T, et al.
BMC Pregnancy Childbirth. 2022;22(1):288
Leggi